PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Central Valley Cardiovascular Associates, Inc., 1148 Norman Drive, Suite #2, Manteca, CA 95336, USA. Electronic address: vemani@yahoo.com.\', \'San Joaquin Critical Care Medical Group, 1801 E March Ln c300, Stockton, CA 95210, USA.\', \'Synergy Med, 1801 E March Ln STE D460, Stockton, CA 95210, USA.\', \'Central Valley Cardiovascular Associates, Inc., 1148 Norman Drive, Suite #2, Manteca, CA 95336, USA.\', \'Stockton Primary Care, 805 N California St #102, Stockton, CA 95204, USA.\']
?:citedBy
  • -1
?:creator
?:doi
?:doi
  • S0924-8579(20)30433-710.1016/j.ijantimicag.2020.106222
?:hasPublicationType
?:journal
  • International journal of antimicrobial agents
is ?:pmid of
?:pmid
?:pmid
  • 33189891
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 1.699
?:rankingScore_hIndex
  • 107
?:title
  • Randomised controlled trials for COVID-19: evaluation of optimal randomisation methodologies-need for data validation of the completed trials and to improve ongoing and future randomised trial designs.
?:type
?:year
  • 2021

Metadata

Anon_0  
expand all